Clinical Trials Browser

INDUSTRY × Recurrence × romidepsin × Clear all

NCT03742921 2023-12-06

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Recurrence, Lymphoma, T-Cell, Peripheral